Moreover, ITGA2 silencing induces apoptosis in gastric cancer [64] and is able to restore sensitivity to paclitaxel in ovarian cancer via inhibition of AKT/FOXO1 signaling [18]. This evidence concerns the gene FOXO1 and ovarian carcinoma.